White, Barbara <br/><br/>
Tumor necrosis factor inhibitors: following best practice.  [electronic resource] 

 -  Managed care (Langhorne, Pa.)  May 2005 
 - 17-23 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1062-3388 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab<br/>Anti-Inflammatory Agents--classification<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Autoimmune Diseases--drug therapy<br/>Etanercept<br/>Formularies as Topic<br/>Health Maintenance Organizations<br/>Humans<br/>Immunoglobulin G--therapeutic use<br/>Immunologic Factors--classification<br/>Infliximab<br/>Medicare<br/>Pharmacy and Therapeutics Committee<br/>Practice Guidelines as Topic<br/>Receptors, Tumor Necrosis Factor--therapeutic use<br/>Treatment Outcome<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors